Craniopharyngioma is a common intracranial congenital tumor that originates from the remnant epithelial cells of the craniopharyngeal duct formed in the primitive oral ectoderm. It can be seen at any age, but is more common in adolescents and about half of them develop in children. The tumor mostly develops in the suprasellar region and may progress to the hypothalamus, paracranial, intersellar, third ventricle, frontal base, and interpeduncular anterior pool. The treatment includes surgery, radiotherapy and drugs, among which surgery is preferred. 1.Surgical treatment: It mainly includes total resection (radical resection), selective subtotal resection, cyst puncture and staged surgery. The purpose of treatment is to remove the tumor to relieve the pressure on the visual cross and other nerve tissues and to lift the cranial hypertension, but it is difficult to restore the hypothalamic-pituitary dysfunction. Because craniopharyngioma is benign, especially for children, total surgical resection should be pursued to prevent recurrence. 2.Radiotherapy: radiotherapy can be tried for those who cannot be completely removed by surgery. Although radiotherapy cannot prevent tumor recurrence, it can prolong the time of tumor recurrence and improve the survival period. At present, most of them adopt extracranial radiotherapy. However, in view of the adverse effects of radiation therapy, especially on the brain development, it is not recommended to carry out radiation therapy for pediatric patients. 3.Drug therapy: There is no special effective drug yet. The effect of surgical treatment varies from person to person, so individualized treatment is currently advocated, and the principle is to strive for maximum removal of tumor without serious complications.